Biosimilars can lower treatment costs for some patients.
生物类似药可以为一些患者降低治疗费用。
After the patent expired, the company launched a biosimilar that was shown in studies to be highly similar to the reference biologic.
在专利到期后,这家公司推出了一款生物类似药,研究显示它与参考生物制剂高度相似。